INTERNATIONAL PATENT: NANJING GENTAI PHARMACEUTICAL TECHNOLOGY CO., LTD., 南京亘泰医药技术有限公司 FILES APPLICATION FOR "PARP1 AND ULK1 DUAL-TARGET INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-07-14

GENEVA, July 14 -- NANJING GENTAI PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 1008, Building D6, No.9 Weidi Road, Xianlin University, Xianlin Street, Qixia DistrictNanjing, Jiangsu 210000), 南京亘泰医药技术有限公司 (中国江苏省南京市栖霞区仙林街道仙林大学城纬地路9号D6栋1008室) filed a patent application (PCT/CN2024/138316) for "PARP1 AND ULK1 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF" on Dec 11, 2024. With publication no. WO/2025/145868, the details related to the patent application was publ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: NANJING GENTAI PHARMACEUTICAL TECHNOLOGY CO., LTD., 南京亘泰医药技术有限公司 FILES APPLICATION FOR "PARP1 AND ULK1 DUAL-TARGET INHIBITOR AND PREPARATION METHOD THEREFOR AND USE THEREOF"